Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Stegemann

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Veterinary Microbiology|December 23, 2011
A proposal of interpretive criteria for cefoperazone applicable to bovine mastitis pathogensAndrea T Fessler, Heike Kaspar, Cynthia J Lindeman, et al.
Veterinary Dermatology|February 18, 2015
Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of lifeSallie B Cosgrove, Dawn M Cleaver, Vickie L King, et al.
Journal of Veterinary Pharmacology and Therapeutics|September 16, 2010
The pharmacokinetics of mavacoxib, a long-acting COX-2 inhibitor, in young adult laboratory dogsS R Cox, S P Lesman, J F Boucher, et al.
Journal of Veterinary Pharmacology and Therapeutics|December 17, 2013
The pharmacokinetics of oclacitinib maleate, a Janus kinase inhibitor, in the dogW T Collard, B D Hummel, A F Fielder, et al.
Journal of the American Veterinary Medical Association|August 5, 2008
Efficacy and safety of cefovecin in treating bacterial folliculitis, abscesses, or infected wounds in dogsRobert Six, Judy Cherni, Robert Chesebrough, et al.
Veterinary Dermatology|March 4, 2014
A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitisSallie B Cosgrove, Jody A Wren, Dawn M Cleaver, et al.
Journal of the American Veterinary Medical Association|January 6, 2009
Effectiveness and safety of cefovecin sodium, an extended-spectrum injectable cephalosporin, in the treatment of cats with abscesses and infected woundsRobert Six, Dawn M Cleaver, Cindy J Lindeman, et al.
Veterinary Dermatology|July 9, 2013
Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitisSallie B Cosgrove, Jody A Wren, Dawn M Cleaver, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Veterinary Microbiology|December 23, 2011
A proposal of interpretive criteria for cefoperazone applicable to bovine mastitis pathogensAndrea T Fessler, Heike Kaspar, Cynthia J Lindeman, et al.
Veterinary Dermatology|February 18, 2015
Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of lifeSallie B Cosgrove, Dawn M Cleaver, Vickie L King, et al.
Journal of Veterinary Pharmacology and Therapeutics|September 16, 2010
The pharmacokinetics of mavacoxib, a long-acting COX-2 inhibitor, in young adult laboratory dogsS R Cox, S P Lesman, J F Boucher, et al.
Journal of Veterinary Pharmacology and Therapeutics|December 17, 2013
The pharmacokinetics of oclacitinib maleate, a Janus kinase inhibitor, in the dogW T Collard, B D Hummel, A F Fielder, et al.
Journal of the American Veterinary Medical Association|August 5, 2008
Efficacy and safety of cefovecin in treating bacterial folliculitis, abscesses, or infected wounds in dogsRobert Six, Judy Cherni, Robert Chesebrough, et al.
Veterinary Dermatology|March 4, 2014
A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitisSallie B Cosgrove, Jody A Wren, Dawn M Cleaver, et al.
Journal of the American Veterinary Medical Association|January 6, 2009
Effectiveness and safety of cefovecin sodium, an extended-spectrum injectable cephalosporin, in the treatment of cats with abscesses and infected woundsRobert Six, Dawn M Cleaver, Cindy J Lindeman, et al.
Veterinary Dermatology|July 9, 2013
Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitisSallie B Cosgrove, Jody A Wren, Dawn M Cleaver, et al.
Pageof 3